ArticleBioinformatics (Oxford, England)2014
Inductive matrix completion for predicting gene-disease associations.
Article in Bioinformatics (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
62 citing papers in PubMed, 340 citations in OpenAlex.
- CSDPCDA: A miRNA-Mediated Cross-Semantic Regulatory Network Framework for Predicting circRNA-Disease Associations.International journal of molecular sciences · 2026Article
- DOMAIN-AWARE MATRIX COMPLETION FOR PHENOTYPE IMPUTATION USING ELECTRONIC HEALTH RECORD DATA WITH APPLICATIONS IN GENOMIC RESEARCH.The annals of applied statistics · 2026Article
- Prediction of miRNA-disease association based on multisource inductive matrix completion.Scientific reports · 2024Article
- MGACL: Prediction Drug-Protein Interaction Based on Meta-Graph Association-Aware Contrastive Learning.Biomolecules · 2024Article
- Heterogeneous biomedical entity representation learning for gene-disease association prediction.Briefings in bioinformatics · 2024Article
- NGCN: Drug-target interaction prediction by integrating information and feature learning from heterogeneous network.Journal of cellular and molecular medicine · 2024Article
- Predicting drug-protein interactions by preserving the graph information of multi source data.BMC bioinformatics · 2024Article
- Current and future directions in network biology.Bioinformatics advances · 2024Article
- Toward Unified AI Drug Discovery with Multimodal Knowledge.Health data science · 2024Article
- ReGeNNe: genetic pathway-based deep neural network using canonical correlation regularizer for disease prediction.Bioinformatics (Oxford, England) · 2023Article
- Drug-target interaction prediction based on spatial consistency constraint and graph convolutional autoencoder.BMC bioinformatics · 2023Article
- DRaW: prediction of COVID-19 antivirals by deep learning-an objection on using matrix factorization.BMC bioinformatics · 2023Article
- From Bilinear Regression to Inductive Matrix Completion: A Quasi-Bayesian Analysis.Entropy (Basel, Switzerland) · 2023Article
- DeepMPF: deep learning framework for predicting drug-target interactions based on multi-modal representation with meta-path semantic analysis.Journal of translational medicine · 2023Article
- Improving Network Representation Learning via Dynamic Random Walk, Self-Attention and Vertex Attributes-Driven Laplacian Space Optimization.Entropy (Basel, Switzerland) · 2022Article
- M2PP: a novel computational model for predicting drug-targeted pathogenic proteins.BMC bioinformatics · 2022Article
- Predicting miRNA-Disease Association Based on Neural Inductive Matrix Completion with Graph Autoencoders and Self-Attention Mechanism.Biomolecules · 2022Article
- Identifying lncRNA-disease association based on GAT multiple-operator aggregation and inductive matrix completion.Frontiers in genetics · 2022Article
- Mining hidden knowledge: embedding models of cause-effect relationships curated from the biomedical literature.Bioinformatics advances · 2022Article
- Exploring complex and heterogeneous correlations on hypergraph for the prediction of drug-target interactions.Patterns (New York, N.Y.) · 2021Article
2 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
motivationMost existing methods for predicting causal disease genes rely on specific type of evidence, and are therefore limited in terms of applicability. More often than not, the type of evidence available for diseases varies-for example, we may know linked genes, keywords associated with the disease obtained by mining text, or co-occurrence of disease symptoms in patients. Similarly, the type of evidence available for genes varies-for example, specific microarray probes convey information only for certain sets of genes. In this article, we apply a novel matrix-completion method called Inductive Matrix Completion to the problem of predicting gene-disease associations; it combines multiple types of evidence (features) for diseases and genes to learn latent factors that explain the observed gene-disease associations. We construct features from different biological sources such as microarray expression data and disease-related textual data. A crucial advantage of the method is that it is inductive; it can be applied to diseases not seen at training time, unlike traditional matrix-completion approaches and network-based inference methods that are transductive.
resultsComparison with state-of-the-art methods on diseases from the Online Mendelian Inheritance in Man (OMIM) database shows that the proposed approach is substantially better-it has close to one-in-four chance of recovering a true association in the top 100 predictions, compared to the recently proposed Catapult method (second best) that has <15% chance. We demonstrate that the inductive method is particularly effective for a query disease with no previously known gene associations, and for predicting novel genes, i.e. genes that are previously not linked to diseases. Thus the method is capable of predicting novel genes even for well-characterized diseases. We also validate the novelty of predictions by evaluating the method on recently reported OMIM associations and on associations recently reported in the literature. AVAILABILITY: Source code and datasets can be downloaded from http://bigdata.ices.utexas.edu/project/gene-disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.